ShanghaiTech University Knowledge Management System
Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis | |
2019-06-07 | |
发表期刊 | MOLECULAR THERAPY-NUCLEIC ACIDS (IF:6.5[JCR-2023],6.7[5-Year]) |
ISSN | 2162-2531 |
卷号 | 16页码:494-504 |
发表状态 | 已发表 |
DOI | 10.1016/j.omtn.2019.04.002 |
摘要 | MicroRNAs (miRNAs) act as regulators of aging at the tissue or organism level or as regulators of cellular senescence. Targeted deletion of miR-126 in mice causes partial embryonic lethality, but its biological function in the liver is still largely unknown. Here, we deleted miR-126a, using the CRISPR/Cas9 system in vitro and in vivo. miR-126a was reduced in the aging livers, and disruption of miR-126a in bone mesenchymal stem cells (BMSCs) induced age-associated telomere shortening, DNA damage responses, and proinflammatory cytokines. Moreover, disruption of miR-126a in mice caused hepatocyte senescence, inflammation, and metabolism deficiency. In addition, disruption of miR-126a via BMSC transplantation aggravated the severity of liver defects induced by cholestasis compared with that in the functional miR-126a BMSC group. Mechanistically, we identified versican (VCAN) as a novel direct miR-126a-5p target that induces telomere shortening, BMSC senescence, and nuclear factor kappa B (NF-kappa B) pathway activation. This study identified aging-related reduced expression of miR-126a and promotion of its target VCAN as a key mechanism in the regulation of hepatic metabolic function during aging and hepatic damage by inducing NF-kappa B pathway activation, DNA repair function disorder, and telomere attrition. The findings indicate that miR-126a may be a drug target for the treatment of hepatic failure. |
收录类别 | SCI ; SCIE |
语种 | 英语 |
资助项目 | Fundamental Research Funds for the Central Universities[2662017PY106] ; Fundamental Research Funds for the Central Universities[2662016PY087] ; Fundamental Research Funds for the Central Universities[2662019YJ008] |
WOS研究方向 | Research & Experimental Medicine |
WOS类目 | Medicine, Research & Experimental |
WOS记录号 | WOS:000470250900044 |
出版者 | CELL PRESS |
WOS关键词 | MESENCHYMAL STEM-CELLS ; HEPATOCELLULAR-CARCINOMA ; SENESCENCE ; LIVER ; MICRORNAS ; AGE ; ATHEROSCLEROSIS ; PROLIFERATION ; TELOMERES ; VERSICAN |
原始文献类型 | Article |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/48977 |
专题 | 生命科学与技术学院_PI研究组_黄行许组 |
通讯作者 | Zhang, Lisheng |
作者单位 | 1.Huazhong Agr Univ, Coll Vet Med, Biomed Ctr, Wuhan 430070, Hubei, Peoples R China 2.Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China 3.Wuhan Univ, Hubei Canc Hosp, Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Wuhan 430079, Hubei, Peoples R China 4.City Hope Natl Med Ctr, Diabet & Metab Res Inst, Beckman Res Inst, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA 5.Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Nephrol, Dept Nephrol, State Key Lab Kidney Dis,Natl Clin Res Ctr Kidney, 28th Fuzing Rd, Beijing 100853, Peoples R China |
推荐引用方式 GB/T 7714 | Yan, Yi,Qin, Dan,Hu, Bian,et al. Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis[J]. MOLECULAR THERAPY-NUCLEIC ACIDS,2019,16:494-504. |
APA | Yan, Yi.,Qin, Dan.,Hu, Bian.,Zhang, Chunjing.,Liu, Shenghui.,...&Zhang, Lisheng.(2019).Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis.MOLECULAR THERAPY-NUCLEIC ACIDS,16,494-504. |
MLA | Yan, Yi,et al."Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis".MOLECULAR THERAPY-NUCLEIC ACIDS 16(2019):494-504. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[Yan, Yi]的文章 |
[Qin, Dan]的文章 |
[Hu, Bian]的文章 |
百度学术 |
百度学术中相似的文章 |
[Yan, Yi]的文章 |
[Qin, Dan]的文章 |
[Hu, Bian]的文章 |
必应学术 |
必应学术中相似的文章 |
[Yan, Yi]的文章 |
[Qin, Dan]的文章 |
[Hu, Bian]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。